Evaluating microvascular reactivity in heart transplant patients
Official title: The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients
Run by National Institute of Cardiology, Laranjeiras, Brazil · NCT05729009 · Data updated 2026-11-12
This study looks at how blood flow in small blood vessels changes in heart transplant patients before and two years after their surgery to see if it can help predict long-term health issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 31 (estimated) |
| Sponsor | National Institute of Cardiology, Laranjeiras, Brazil Government |
| Locations | 1 site (Rio de Janeiro) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT05729009 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult patients undergoing heart transplantation who can understand the study objectives and provide informed consent.
✕Probably not a fit
Patients who are pregnant, have acute infections, or use circulatory assistance devices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the evolution of systemic microvascular reactivity in adult heart transplant patients before and two years after transplantation. Using non-invasive techniques such as laser speckle contrast imaging and acetylcholine iontophoresis, the study will evaluate skin microcirculation and correlate findings with clinical variables, hemodynamic, and echocardiographic data. The goal is to identify prognostic factors related to graft vascular disease, which is a leading cause of long-term mortality in heart transplant patients.
Why it matters
Potential benefit: If successful, this study could provide insights into cardiovascular physiology and improve non-invasive evaluation methods for heart transplant patients.
How similar studies have gone: While the approach of evaluating microvascular reactivity is established, the specific application in heart transplant patients is novel and not extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * capability to understand the objectives of the research and to fulfill the Term of Consent Exclusion Criteria: * Pregnancy, acute infection diagnosis, use of circulatory assistance devices
Where it's running
-
Eduardo Tibiriçá
Rio de Janeiro, Brazil Recruiting
Study contacts
- Study coordinator: Eduardo Tibirica Tibirica, MD, PhD
- Email: etibi@uol.com.br
- Phone: +55-21-99914-6075
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nationwide Swedish program testing donor-derived cell-free DNA to monitor rejection after heart transplant
This project tests whether a blood test measuring donor-derived cell-free DNA can help monitor rejection in adults who have had a heart transplant.
-
Metabolic deterioration after heart transplant determines outcomes
We'll test whether worsening cardiac and systemic metabolism after a heart transplant predicts heart function and long-term survival in adult transplant recipients.
-
Mapping fat-cell sizes around the coronary arteries to trace inflammation
This project will test whether differences in fat-cell size next to the coronary arteries can show how inflammation spreads in people having a heart transplant for advanced heart failure.
-
Multimodal analysis of heart biopsy samples
This project will take one extra small heart biopsy during a clinically needed procedure to test whether detailed molecular and immune analyses can find disease-specific signatures in adults with cardiomyopathies, myocarditis, cardiac amyloidosis, or after heart transplant.
-
Long-term health of children born to mothers who had a solid organ transplant
This project will look for long-term heart, kidney, and immune system problems in people aged 16 and older who were born to mothers who had a kidney, liver, pancreas, heart, or lung transplant.
-
Cardiac rehabilitation cohort at Medicine Campus Davos to explore recovery
This project will follow adults coming to Hochgebirgsklinik Davos for cardiac rehabilitation to see how their heart health and recovery progress over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.